Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for aspiration therapy
- PMID: 33218669
- DOI: 10.1016/j.gie.2020.09.021
Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for aspiration therapy
Abstract
A subcommittee of the Association for Bariatric Endoscopy, a division of the American Society for Gastrointestinal Endoscopy (ASGE) comprising experts in the subject area, performed this systematic review and meta-analysis. The systematic review and meta-analysis was reviewed by the ASGE Technology Committee and was ultimately submitted to the ASGE Governing Board for approval. The systematic review and meta-analysis underwent peer review by outside experts in statistics and meta-analysis before receiving final ASGE Governing Board approval. The Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) initiative is an ASGE program whose objectives are to identify important clinical questions related to endoscopy and to establish a priori diagnostic and/or therapeutic thresholds for endoscopic technologies designed to resolve these clinical questions. Once endoscopic technologies meet an established PIVI threshold, those technologies are appropriate to incorporate into clinical practice, presuming the appropriate training in that endoscopic technology has been achieved. ASGE encourages and supports the appropriate use of technologies that meet its established PIVI thresholds.
Copyright © 2021 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps.Gastrointest Endosc. 2011 Mar;73(3):419-22. doi: 10.1016/j.gie.2011.01.023. Gastrointest Endosc. 2011. PMID: 21353837
-
ASGE guideline on minimum staffing requirements for the performance of GI endoscopy.Gastrointest Endosc. 2020 Apr;91(4):723-729.e17. doi: 10.1016/j.gie.2019.12.002. Epub 2020 Feb 6. Gastrointest Endosc. 2020. PMID: 32033801
-
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on peroral endoscopic myotomy.Gastrointest Endosc. 2015 May;81(5):1087-100.e1. doi: 10.1016/j.gie.2014.12.007. Epub 2015 Mar 19. Gastrointest Endosc. 2015. PMID: 25799295 No abstract available.
-
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) on the use of endoscopy simulators for training and assessing skill.Gastrointest Endosc. 2012 Sep;76(3):471-5. doi: 10.1016/j.gie.2012.03.248. Epub 2012 Jul 17. Gastrointest Endosc. 2012. PMID: 22809879 Review. No abstract available.
-
The current state of bariatric endoscopy.Dig Endosc. 2021 Mar;33(3):321-334. doi: 10.1111/den.13698. Epub 2020 Oct 28. Dig Endosc. 2021. PMID: 32301158 Review.
Cited by
-
Endoscopic Bariatric Therapy for Obesity and Metabolic Syndrome.Korean J Helicobacter Up Gastrointest Res. 2023 Dec;23(4):247-253. doi: 10.7704/kjhugr.2023.0049. Epub 2023 Dec 8. Korean J Helicobacter Up Gastrointest Res. 2023. PMID: 40503504 Free PMC article. Review.
-
Primary Bariatric Procedures.Dig Dis Sci. 2022 May;67(5):1674-1687. doi: 10.1007/s10620-022-07393-z. Epub 2022 Mar 29. Dig Dis Sci. 2022. PMID: 35348970 Review.
-
Impact of innovative technologies on quality and safety in surgery.J Robot Surg. 2024 Dec 20;19(1):31. doi: 10.1007/s11701-024-02192-2. J Robot Surg. 2024. PMID: 39707082 Review.
-
Endoscopic gastroplasty: an effective solution in a high-risk patient with morbid obesity.Clin J Gastroenterol. 2021 Apr;14(2):489-493. doi: 10.1007/s12328-020-01322-1. Epub 2021 Jan 11. Clin J Gastroenterol. 2021. PMID: 33428066
-
Endoscopic Bariatric and Metabolic Therapies for Liver Disease: Mechanisms, Benefits, and Associated Risks.J Clin Transl Hepatol. 2022 Oct 28;10(5):986-994. doi: 10.14218/JCTH.2021.00448. Epub 2022 Feb 21. J Clin Transl Hepatol. 2022. PMID: 36304503 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources